Pleopharma, Inc.
Malvern, PA
- UEI
- NSW8A6YH85C1
- CAGE
- 9VNF4
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 212 Mine Rd, Malvern, PA 19355, USA
- Website
- pleopharma.com
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Phase 3 trial of PP-01 for mitigation of cannabis withdrawal in CUD - project summary cannabis use disorder (CUD)… | National Institute on Drug Abuse | $2,199,962 |
Quick answers
What is Pleopharma, Inc.'s UEI?
Pleopharma, Inc.'s Unique Entity ID (UEI) in SAM.gov is NSW8A6YH85C1.
What is Pleopharma, Inc.'s CAGE code?
Pleopharma, Inc.'s CAGE code is 9VNF4.
What is Pleopharma, Inc.'s primary NAICS code?
Pleopharma, Inc.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).
Where is Pleopharma, Inc. located?
Pleopharma, Inc.'s physical address in SAM.gov is 212 Mine Rd, Malvern, PA 19355, USA.
Is Pleopharma, Inc. registered in SAM.gov?
Yes. Pleopharma, Inc.'s SAM.gov registration is active through July 6, 2027.
What is Pleopharma, Inc.'s most recent federal award?
Pleopharma, Inc.'s most recent federal grant award is Phase 3 trial of PP-01 for mitigation of cannabis withdrawal in CUD - project summary cannabis use disorder (CUD)… (U01DA066079), from National Institute on Drug Abuse, on August 15, 2026.
On GovTribe
See Pleopharma, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors